Investors of Prestige Consumer Healthcare Inc. Invited to Join Ongoing Fraud Investigation

Investor Alert: Join the Fraud Investigation of Prestige Consumer Healthcare Inc.

In recent developments, the Schall Law Firm, renowned for advocating shareholder rights, is launching an investigation into potential fraud claims impacting investors of Prestige Consumer Healthcare Inc. (NYSE: PBH). This inquiry arises from concerns regarding possible violations of securities laws and misleading information provided by the company to its shareholders.

Background on Prestige Consumer Healthcare Inc.

Prestige Consumer Healthcare, a significant player in the healthcare sector, has faced scrutiny following the release of its Q4 and full year 2026 financial results on May 13, 2026. Key revelations from this report indicate an organic revenue decline of 4.5% compared to the previous year, as well as a concerning stagnation in total adjusted gross margin, which remained nearly unchanged at 55.6%, down slightly from 55.8% in the prior year. These troubling figures prompted a notable drop of 11.35% in the company's stock price the following day, triggering fears among investors about the company's stability and transparency.

The Investigation

The core of the Schall Law Firm's investigation revolves around whether Prestige misled its investors by issuing false or incomplete information regarding its financial health. Given the significant implications this may have on shareholders, the firm is reaching out to affected investors to gauge the extent of the losses incurred due to these revelations.

Brian Schall, a leading attorney at the firm, has advised investors who feel they may have been misled or who have suffered financial setbacks to come forward and discuss their rights. The firm is offering consultations at no charge to those who wish to participate in the investigation and seek potential redress for their losses. Such inquiries are critical for holding companies accountable for their actions and ensuring investors receive the information necessary to make informed decisions.

Your Opportunity to Act

If you hold shares in Prestige Consumer Healthcare and believe you have experienced losses attributable to misleading statements or omissions, now is the time to act. Joining the investigation could empower you to pursue your rights as an investor and potentially recover losses through class action litigation.

To participate in this investigation or to learn more about your options, individuals can contact Brian Schall directly at the Schall Law Firm's office located at 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, or reach him at 310-301-3335. Further details and ongoing updates can also be found on the firm's official website at www.schallfirm.com.

The Schall Law Firm remains dedicated to representing investors’ interests and actively pursuing cases of shareholder fraud. As the case against Prestige Consumer Healthcare Inc. develops, it underscores the importance of transparency and accountability within the corporate sector, highlighting the risks investors face when companies fail to uphold their trust and provide accurate information.

Stay informed and take proactive steps to protect your investments as this situation unfolds. The outcome of this investigation could significantly affect many stakeholders involved with Prestige Consumer Healthcare.